These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12753906)

  • 1. Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners.
    Loregian A; Bortolozzo K; Boso S; Caputo A; Palù G
    FEBS Lett; 2003 May; 543(1-3):61-5. PubMed ID: 12753906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein.
    Loregian A; Bortolozzo K; Boso S; Sapino B; Betti M; Biasolo MA; Caputo A; Palú G
    J Cell Physiol; 2003 Aug; 196(2):251-7. PubMed ID: 12811817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.
    Kim YS; Kim JM; Jung DL; Kang JE; Lee S; Kim JS; Seol W; Shin HC; Kwon HS; Van Lint C; Hernandez N; Hur MW
    J Biol Chem; 2005 Jun; 280(22):21545-52. PubMed ID: 15743774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
    Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
    J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes.
    Rossi A; Mukerjee R; Ferrante P; Khalili K; Amini S; Sawaya BE
    J Gen Virol; 2006 Jun; 87(Pt 6):1613-1623. PubMed ID: 16690926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.
    Chun RF; Semmes OJ; Neuveut C; Jeang KT
    J Virol; 1998 Apr; 72(4):2615-29. PubMed ID: 9525578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between Tat of HIV-2 and transcription factor Sp1.
    Pagtakhan AS; Tong-Starksen SE
    Virology; 1997 Nov; 238(2):221-30. PubMed ID: 9400595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.
    Suñé C; García-Blanco MA
    J Virol; 1995 Oct; 69(10):6572-6. PubMed ID: 7666561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
    Huang LM; Jeang KT
    J Virol; 1993 Dec; 67(12):6937-44. PubMed ID: 8230415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
    Jeyapaul J; Seshamma T; Khan SA
    Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
    Veschambre P; Simard P; Jalinot P
    J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptosis, and changes Sp1 DNA binding in HeLa cells.
    Seve M; Favier A; Osman M; Hernandez D; Vaitaitis G; Flores NC; McCord JM; Flores SC
    Arch Biochem Biophys; 1999 Jan; 361(2):165-72. PubMed ID: 9882443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation.
    Wu-Baer F; Lane WS; Gaynor RB
    J Mol Biol; 1998 Mar; 277(2):179-97. PubMed ID: 9514752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.
    Kashanchi F; Agbottah ET; Pise-Masison CA; Mahieux R; Duvall J; Kumar A; Brady JN
    J Virol; 2000 Jan; 74(2):652-60. PubMed ID: 10623726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.